Laboratory Corp of America Holdings (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 402,400 | 213,300 | 1,280,600 | 1,204,200 | 851,000 |
| Depreciation Amortization | 285,000 | 142,100 | 537,200 | 406,800 | 273,900 |
| Income taxes - deferred | 16,200 | 27,200 | 26,300 | -44,800 | -23,900 |
| Accounts receivable | -33,500 | -51,500 | 23,100 | -4,800 | -17,000 |
| Accounts payable and accrued liabilities | -160,300 | -77,700 | 285,400 | 112,600 | 112,500 |
| Other Working Capital | -478,100 | -277,200 | -353,200 | -394,200 | -200,300 |
| Other Operating Activity | 440,900 | 145,000 | 156,500 | 22,500 | -67,700 |
| Operating Cash Flow | $472,600 | $121,200 | $1,955,900 | $1,302,300 | $928,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -17,400 | N/A | 400 |
| PPE Investments | -181,300 | -78,100 | -427,900 | -329,000 | -246,300 |
| Net Acquisitions | -136,900 | 200 | -1,162,400 | -1,013,600 | -554,900 |
| Purchase Of Investment | -10,400 | -6,100 | N/A | -6,100 | -4,700 |
| Sale Of Investment | N/A | N/A | 5,200 | 700 | N/A |
| Other Investing Activity | -24,700 | -15,700 | -49,700 | -30,900 | -10,100 |
| Investing Cash Flow | $-353,300 | $-99,700 | $-1,652,200 | $-1,378,900 | $-815,600 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,420,900 | 827,900 | 787,400 | N/A | N/A |
| Debt Repayment | -1,420,900 | -827,900 | -787,400 | N/A | N/A |
| Common Stock Issued | 54,400 | 27,600 | 50,600 | 50,600 | 19,100 |
| Common Stock Repurchased | 0 | N/A | -1,100,000 | -800,000 | -400,000 |
| Dividend Paid | -129,000 | -64,400 | -195,200 | -131,600 | -66,700 |
| Other Financing Activity | 1,559,000 | -23,800 | -77,600 | -68,600 | -49,800 |
| Financing Cash Flow | $1,484,400 | $-60,600 | $-1,322,200 | $-949,600 | $-497,400 |
| Exchange Rate Effect | 6,300 | 3,000 | -24,200 | -36,600 | -19,400 |
| Beginning Cash Position | 320,600 | 330,900 | 1,363,300 | 1,367,700 | 1,382,200 |
| End Cash Position | 1,930,600 | 294,800 | 320,600 | 304,900 | 978,300 |
| Net Cash Flow | $1,610,000 | $-36,100 | $-1,042,700 | $-1,062,800 | $-403,900 |
| Free Cash Flow | |||||
| Operating Cash Flow | 472,600 | 121,200 | 1,955,900 | 1,302,300 | 928,500 |
| Capital Expenditure | -181,500 | -78,200 | -429,300 | -330,200 | -247,400 |
| Free Cash Flow | 291,100 | 43,000 | 1,526,600 | 972,100 | 681,100 |